Efficacy of three consecutive therapeutic plasma exchanges in major ABO‐incompatible hematopoietic stem cell transplantation
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Clinical Apheresis"
DOI: 10.1002/jca.21680
Abstract: We retrospectively analyzed data of recipients who underwent three consecutive therapeutic plasma exchanges (TPEs) before major ABO‐incompatible (ABOi) hematopoietic stem cell transplantation (HSCT) in our hospital from 2012 to 2017 and evaluated the efficacy of… read more here.
Keywords: three consecutive; plasma exchanges; abo incompatible; consecutive therapeutic ... See more keywords
Successful treatment of refractory pure red cell aplasia in major ABO-mismatched allogeneic hematopoietic stem cell transplant with single agent Ibrutinib
Sign Up to like & getrecommendations! Published in 2022 at "Bone Marrow Transplantation"
DOI: 10.1038/s41409-022-01590-0
Abstract: TO THE EDITOR: Allogeneic hematopoietic stem cell transplant (allo-HCT) is a potentially curative treatment for several malignant and nonmalignant hematological disorders. The basis of allo-HCT is the matching of human leukocyte antigen (HLA), which is… read more here.
Keywords: red cell; prca; treatment; cell ... See more keywords
Immunohaematological events related to changes in haematic and seric ABO group in patients undergoing haematopoietic stem cell transplantation with major ABO mismatch
Sign Up to like & getrecommendations! Published in 2019 at "Transfusion Medicine"
DOI: 10.1111/tme.12538
Abstract: Dear Sir, Haematopoietic stem cell transplantation (HSCT) from ABO red cell-incompatible donors has been reported in up to half of the cases by several authors (Rowley et al., 2011). A major ABO mismatch is defined… read more here.
Keywords: seric abo; group; abo; abo mismatch ... See more keywords